Mini Review - Archives of Gastroenterology Research (2021) Volume 2, Issue 1
Updates in the Treatment of Superficial Gastric Neoplasms by Endoscopic Submucosal Dissection
Josue Aliaga Ramos1*, Vitor N. Arantes2
1Faculty of Medicine “Alberto Hurtado”, Cayetano Heredia Peruvian University, Digestive Endoscopy Unit of the San Pablo Clinic, Surco, Lima, Peru; Member of the Gastroenterology Society of Peru
2Endoscopy Unit, Alfa Institute of Gastroenterology, Federal University of Minas Gerais, Mater Dei Contorno Hospital, Belo Horizonte, Minas Gerais, Brazil
- *Corresponding Author:
- Vitor Arantes
Received date: December 09, 2020; Accepted date: January 25, 2021
Citation: Aliaga-Ramos J, Arantes V. Updates in the Treatment of Superficial Gastric Neoplasms by Endoscopic Submucosal
Dissection. Arch Gastroenterol Res. 2021; 2(1): 26-30.
Copyright: © 2021 Aliaga-Ramos J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Gastric cancer is one of the neoplasms with the highest degree of mortality worldwide, responsible for more than 780,000 deaths in
2018 and whose incidence has been increasing over the last few years, mainly in Asian and Latin American countries.
The technological imaging advances in digestive endoscopy such as virtual chromoendoscopy and magnification associated with a
systematic and comprehensive endoscopic examination of the entire gastric mucosa by a trained operator have optimized the early
detection of pre-malignant and malignant lesions, which have favoured the high rate of curability through the use of endoscopic
resection techniques such as endoscopic submucosal dissection (ESD).
ESD is one of the techniques in advanced therapeutic endoscopy that has revolutionized the management of early neoplasms of
the gastrointestinal tract, demonstrating excellent results that are as equally efficient as surgery in the medium and long-term, but
avoiding the post-operative morbi-mortality associated with surgical interventions and also presenting a low rate of adverse events in
expert hands. This review has the objective to discuss the most recent advances in the management of superficial gastric neoplasms
and to present an algorithm approach for these types of lesions.
ESD is currently the first-line of treatment in the eradication of the pre-malignant and early malignant neoplasms, demonstrating in most studies, mainly from Asia, high rates of efficiency and safety in expert hands. This also reinforces the concept of early detection of pre-malignant and malignant lesions using virtual chromoendoscopy/endoscopic magnification techniques associated with a systematic and sequential revision, based on an endoluminal endoscopic anatomy [1-3].
For many years, gastrectomy has been considered the standard treatment for early gastric cancer, however it is associated with post-surgical morbidity and mortality, particularly high surgical risks patients. Japanese pioneers developed ESD as an alternative for the eradication of this type of early gastric neoplasms with great advantages over conventional surgery, as demonstrated in different comparative studies [4-9]. Liu et al.  recently reported a
meta-analysis in which they included 18 studies with 5,993
patients, observing the following benefits of ESD with
respect to surgery: 1) shorter duration of the procedure
(128.38 min; 95%CI: (-204.68, -52.09), p=0.001); 2)
shorter hospital stay (7.13 days; 95%CI: (-7.98, -6.28),
p<0.00001); 3) lower risk of death associated with the
procedure (OR=0.21; 95%CI: (0.07, 0.68), p=0.009);
4) lower risk of complications (OR=0.47; 95%CI: (0.34,
0.63), p<0.00001) and 5) lower costs and better quality of
life. Outcomes that are corroborated with those obtained
by our research group. In order to obtain a high curative
rate some principles should be followed: adequate
selection of patients through a thorough evaluation of the
lesions using enhanced imaging endoscopic techniques such as virtual chromoendoscopy and magnification by
an expert operator [11,12] ; precise tumor delineation in
order to achieve a complete (R0) and en bloc resection of
the target-lesion; preparation and fixation of the specimen
for histological analysis by an experienced gastrointestinal
pathologist and correct interpretation of the histological
results in order to determine if a curative resection was
obtained meeting the curability criteria proposed by the
last Japanese guideline  .
It is essential to highlight the importance of endoscopic surveillance in all patients that undergoes gastric ESD aiming to detect local recurrences or metachronic lesions . Emura et al. . proposed a methodology for a highquality upper gastrointestinal endoscopy with a systematic revision of the upper digestive tract defined as SACE (Systematic Alphanumeric Coded Endoscopy), establishing 28 areas of analysis, 21 of which belong to the stomach, in order to generate a complete and meticulous evaluation of the entire gastric mucosa detecting pre-malignant and early malignant lesions. In the aforementioned study, in 650 healthy volunteers used the SACE system and chromoendoscopy a rate of pre-malignant gastric lesions of 30% (195/650) was found, two of which were diagnosed as early gastric cancer and underwent successfully by ESD.
The Latin American experience in ESD is still limited due to the steep learning curve to master the technique, as well as the lack of training centers [16,17]. Recently Arantes et al.  reported one of the largest studies in Latin America including 103 ESD procedures for superficial gastric neoplasms, demonstrating an overall en-bloc resection rate of 96.3% with 97.1% (34/35) for pre-malignant lesions and 95.5% (43/45) for malignant lesions. Also, the study demonstrated complete resection (R0) rate of 92.5% with 94.2% (33/35) for pre-malignant lesions and 88.8% (40/45) for malignant lesions. Likewise, a global curative resection rate of 76% (32/42) was determined based on the expanded criteria proposed by the latest Japanese guidelines, with a rate of adverse events of only 2.5% (2/80), which demonstrates an excellent efficiency and safety profile of this resection endoscopic technique in expert hands. Furthermore, follow-up disclosed just one case of local recurrence (1.2%) and identified 3 cases of metachronic lesions (3.7%) during a mean surveillance period of 17 months, demonstrating the great benefits of curative resection for these types of lesions and the importance of annual surveillance to detect metachronous tumors. Another important finding to highlight in this study was that more than 80% of the resected lesions had a size ≥ 20mm located mainly in the lower third of the stomach which were eradicated in an average procedure time of 107 minutes (SD ± 51.6), demonstrating an interesting profile of clinical effectiveness. Of the 80 resected cases in the aforementioned study, 42 were adenocarcinomas (52.5%), 22 were low-grade dysplasia (27.5%), 13 were high-grade dysplasia (16.3%) and 3 were neuroendocrine tumours (3.8%). Likewise, it was observed that 78.5% (33/42) had only intramucosal invasion (T1a) and 21.3% presented submucosal invasion (T1b): 3 cases (7.1%) to superficial submucosa (SM1) and 6 cases (14.2%) to deep submucosa (SM2). In accordance with international oncological guidelines, most non-curative cases (6/10) underwent surgical treatment (gastrectomy). The remaining patients were considered unfit for surgery and underwent endoscopic follow-up and no relapse was noticed during the average follow-up of 22.5 months. Figures 1-3 show a representative case of early detection and characterization of a superficial gastric neoplasm, using virtual chromoendoscopy techniques/endoscopic magnification, also Figures 4-8 detail the main steps of the endoscopic submucosal dissection performed for the eradication of this lesion.
A critical step for the execution of ESD is the creation of a submucosal cushion. For this effect, the research team of this study used 0.4% sodium hyaluronate teardrops for submucosal injection (Adaptis Fresh®, Legrand Laboratory, Brazil). Although there is currently not enough scientific evidence to support the off-label use of this substance for submucosal injection in gastric ESD, the same research group recently published a study in which the benefits of the use of this substance were demonstrated with an optimal safety profile, presenting promising results, and appearing as an excellent alternative in the Western countries that have no access to Muco Up®, which
is only available in Japan .
In conclusion our research group reaffirms the importance of high-quality endoscopy examination in all patients with the objective of detecting pre-malignant or early malignant lesions, and the fundamental role of ESD in providing an effective and minimally invasive therapeutic approach to gastric neoplastic lesions, preserving the organ and the quality of life of the affected patients.
- Banks M, Graham D, Jansen M, Gotoda T, Coda S,
Di Pietro M, et al. British Society of Gastroenterology
guidelines on the diagnosis and management of patients
at risk of gastric adenocarcinoma. Gut. 2019 Sep
- Icaza-Chávez ME, Tanimoto MA, Huerta-Iga FM,
Remes-Troche JM, Carmona-Sánchez R, Ángeles-Ángeles
A, et al. Mexican Consensus on Detection and Treatment
of Early Gastric Cancer. Journal of Gastroenterology of
Mexico. 2020 Jan 1; 85 (1): 69-85.
- Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia
M, Leja M, Garrido M, et al. Management of epithelial
precancerous conditions and lesions in the stomach
(maps II): European Society of gastrointestinal endoscopy
(ESGE), European Helicobacter and microbiota Study
Group (EHMSG), European Society of pathology (ESP),
and Sociedade Portuguesa de Endoscopia Digestiva (SPED)
guideline update 2019. Endoscopy. 2019;51(4):365-88.
- Li H, Feng LQ, Bian YY, Yang LL, Liu DX, Huo ZB,
et al. Comparison of endoscopic submucosal dissection
with surgical gastrectomy for early gastric cancer: an
updated meta-analysis. World Journal of Gastrointestinal
Oncology. 2019 Feb 15;11(2):161-71.
- Abdelfatah MM, Barakat M, Ahmad D, Ibrahim
M, Ahmed Y, Kurdi Y, et al. Long-term outcomes of
endoscopic submucosal dissection versus surgery in early
gastric cancer: a systematic review and meta-analysis.
European Journal of Gastroenterology & Hepatology.
2019 Apr 1;31(4):418-24.
- Gu L, Khadaroo PA, Chen L, Li X, Zhu H, Zhong X,
et al. Comparison of long-term outcomes of endoscopic
submucosal dissection and surgery for early gastric
cancer: a systematic review and meta-analysis. Journal of
Gastrointestinal Surgery. 2019; 23:1493-501.
- Shin DW, Hwang HY, Jeon SW. Comparison of
endoscopic submucosal dissection and surgery for
differentiated type early gastric cancer within the expanded
criteria. Clinical Endoscopy. 2017 Mar;50(2):170-8.
- Lee S, Choi KD, Han M, Na HK, Ahn JY, Jung KW,
et al. Long-term outcomes of endoscopic submucosal
dissection versus surgery in early gastric cancer meeting
expanded indication including undifferentiated-type
tumors: a criteria-based analysis. Gastric Cancer. 2018
- Hahn KY, Park CH, Lee YK, Chung H, Park JC, Shin SK,
et al. Comparative study between endoscopic submucosal
dissection and surgery in patients with early gastric cancer.
Surgical Endoscopy. 2018 Jan;32(1):73-86.
- Liu Q, Ding L, Qiu X, Meng F. Updated evaluation of
endoscopic submucosal dissection versus surgery for early
gastric cancer: A systematic review and meta-analysis.
International Journal of Surgery. 2020 Jan 1;73:28-41.
- Yao K, Nagahama T, Matsui T, Iwashita A. Detection
and characterization of early gastric cancer for curative
endoscopic submucosal dissection. Digestive Endoscopy.
- Nakamura M, Shibata T, Tahara T, Yoshioka D,
Okubo M, Mizoguchi Y, et al. The usefulness of magnifying
endoscopy with narrow-band imaging to distinguish
carcinoma in flat elevated lesions in the stomach diagnosed
as adenoma by using biopsy samples. Gastrointestinal
Endoscopy. 2010 May 1;71(6):1070-5.
- Ono H, Yao K, Fujishiro M, Oda I, Nimura S, Yahagi
N, et al. Guidelines for endoscopic submucosal dissection
and endoscopic mucosal resection for early gastric cancer.
Digestive Endoscopy. 2016 Jan;28(1):3-15.
- Quea NR, Emura F, Bolaños FB, Arias YS, Suárez
FA, Rivera AP. Effectiveness of systematic alphanumeric
coded endoscopy for diagnosis of gastric intraepithelial
neoplasia in a low socioeconomic population. Endoscopy
International Open. 2016 Oct;4(10):E1083-9.
- Emura F, Mejía J, Mejía M, Osorio C, Hernández
C, González I, et al. Effectiveness of systematic
chromoendoscopy for diagnosis of early cancer and gastric
premalignant lesions: Results of two consecutive screening
campaigns in Colombia (2006-2007). Revista Colombiana
de Gastroenterologia. 2010 Mar;25(1):18-28.
- Arantes VN, Sanna MD, Alves JS, Milhomem-Cardoso
DM, Maluf-Filho F. Is endoscopic submucosal dissection
still limited to few tertiary centers in the West? Results from
a national survey in Brazil. Arquivos de Gastroenterologia.
- González N, Parra-Blanco A, Arantes V, Mönkemüller
K. Current status of endoscopic submucosal dissection in
Latin America. Acta Gastroenterológica Latinoamericana.
2016; 46 (3): 213-9.
- Arantes V, Aliaga Ramos J, Pedrosa MS. Endoscopic
submucosal dissection for superficial gastric neoplasms in
two referral hospitals in Brazil: Can the Japanese and South
Korean results be equaled? Revista de Gastroenterologia
de Mexico. 2020; 20: 1-9.
- Arantes V, Aliaga Ramos J, Abdul Rani R, Yoshida
N. Off-label use of 0.4% sodium hyaluronate teardrops:
a safe and effective solution for submucosal injection in
gastric endoscopic submucosal dissection. Endoscopy
International Open. 2020; 08(12): E1741-E1747.